The FDA sent 30 warning letters to GLP-1 compounders on February 20, 2026, flagging violations including claims of "same active ingredients" as brand-name drugs, language implying therapeutic equivalence, and statements implying FDA approval of compounded products
Two of the most promising options on the market today are Tirzepatide and Semaglutide
Supports blood flow, improves hair density, and nourishes the skin barrier
Visit our website for more information about how Tesseracts products can help support your neurological health and promote healthy aging.* Citations 1 Richie JP Jr, Nichenametla S, Neidig W, et al
No, there is no known drug interaction between Wegovy (semaglutide) and botulinum toxin products documented in UK product information